Respiratory Diagnostics Market by Product & Services (Instrument & Devices), Test type (Mechanical, OSA, Imaging, Molecular Test), Disease (Tuberculosis, COPD, Lung Cancer ) and Diagnosis Type (Syndromic, Aetiological, Prognosis) - Global Forecast to 2030

The global respiratory diagnostics market is projected to reach USD 9.02 billion by 2030 from USD 6.17 billion in 2024, at a CAGR of 6.5% during the forecast period. The respiratory diagnostics market is driven by many rising impacts with respect to improving cases of respiratory diseases around the world. Innovative technologies in diagnosis, such as molecular diagnostics and advanced imaging solutions, have also improved the accuracy and speed of detection for conditions such as asthma, tuberculosis, or lung cancers. Increased awareness for healthcare providers and patients about the benefits of early diagnosis and more government-sponsored, healthy analysis programs have also served as important fuel sources in the demand for respiratory diagnostic solutions. The COVID-19 pandemic has demonstrated the need for efficient and reliable diagnostics in the management of respiratory infections. However, the market growth is restricted by several factors, including the recent changes in the regulatory framework concerning the approval of new products, their labeling requirements, and complete conformance to quality standards.

""Instruments and Devices segment accounted for the largest share in the respiratory diagnostics market.""

The growing advancements in diagnosis technologies such as diagnostic imaging devices, spirometers, and other respiratory diagnostic instruments have led to such importance in this segment. In addition to this, the rising prevalence of respiratory disease across the globe has greatly increased the demand for advanced and accurate diagnostics tools. The innovations in point-of-care testing devices and portable diagnostic instruments, such as advanced point-of-care testing instruments and portable diagnostic instruments, have enhanced the growth of the Instrument and Devices segment, allowing rapid and accurate respiratory assessment by health professionals. Hence, the above factors are driving respiratory diagnostics market growth in the region.

""The Mechanical tests segment accounted for the largest share in the respiratory diagnostics market.""

Mechanical tests, including tools like spirometers and peak flow meters, are essential for assessing lung function and airflow. The rising incidence of chronic respiratory conditions, such as asthma and COPD, has significantly increased the reliance on these diagnostic methods. Enhanced technological innovations, such as digital spirometry and portable devices, have improved the accuracy, ease of use, and accessibility of mechanical tests, making them more widely adopted in clinical and home settings. Furthermore, the growing emphasis on early diagnosis and continuous monitoring of respiratory health, particularly in managing chronic diseases, is a major driver for the expansion of this segment within the respiratory diagnostics market.

""Asthma segment accounted for the largest share in the global respiratory diagnostics market.""

Increase accession of environmental pollutants, changing lifestyles, and genetic factors contributing to increasing cases in asthma which further necessitates the requirement of advanced diagnostic solutions. Asthma is one of the segments that include diagnostic modalities, pulmonary function tests, imaging techniques, and biomarker assessments, all of which comprise an option for asthma diagnosis and management. However, ongoing research and development initiatives focusing on personalized medicine drive the segment for respiratory diagnostics.

""Syndromic segment has accounted for the largest share in the global respiratory diagnostics market.""

Syndromic segment holds the largest share in the respiratory diagnostics market due to its capabilities of rapid and widespread diagnosis for many pathogens from a single test. The efficiency is very important since in the management of conditions such as influenza and pneumonia, it is vital timeously to identify the causative agent for its effective treatment. Syndromic panels reduce the time in diagnosis and keep for diagnosis, as this promotes early interventions. At the same time, the applications of techniques such as PCR and multiplex assays have improved specificity and access to syndromic panels. Increasing need drives point-of-care testing in hospitals and clinics into adopting syndromic diagnostic solutions.

“Hospitals and clinics end-user segment held the largest market share growing at the highest CAGR during the forecast period of the global respiratory diagnostics market.""

While respiratory diseases proliferate, there has been an surged awareness about the need for their early detection. This has in turn led to an increase in the diagnostic procedures carried out in most of these facilities. The segment Hospitals and Clinics cater to a wide range of diagnostic equipment and services such as imaging studies, pulmonary function tests, and molecular diagnostics; hence it offers a complete solution for respiratory health assessment. As a result, the segment positioning in this whole input-output course of illness diagnosis, management, and therapy clearly puts hospitals and clinics within this input-output chain addressing the emerging demand for respiratory diagnostics in many healthcare institutions.

“North America to witness the fastest CAGR in the respiratory diagnostics market during the forecast period.”

Respiratory diagnostics market has been segmented into five major regional segments: North America, Europe, Asia Pacific, Latin America and Middle East and Africa. In 2023, North America is expected to be in the leading position, holding the largest share of the global respiratory diagnostic market. This leadership position had been fueled by a highly developed healthcare system, along with high prevalence rates of respiratory diseases and considerable expenditure toward innovation in healthcare. According to their advanced diagnostic technologies, the focus is toward accurate and rapid testing; hence, they tend to give all of the parameters, including increased healthcare spending, larger aging populations, and strong emphasis on public health initiatives that are caused by respiratory issues, for example. Their overall regulatory framework encourages the adoption of these diagnostic solutions for continued growth.

Breakdown of supply-side primary interviews: By Company Type: Tier 1 – 35%, Tier 2 – 40%, and Tier 3 – 25% By Designation: C-level – 30%, Director-level – 23%, and Others – 47% By Region: North America - 25%, Europe – 35%, APAC – 20%, Latin America – 13%, Middle East & Africa – 7%

Breakdown of demand-side primary interviews: By Company Type: Hospitals & Clinics – 62%, Diagnostics Laboratories – 16%, and Other End Users – 22% By Designation: Senior Managers – 35%, Chief Officers – 28%, Radiologists – 25% and Other Designations – 12% By Region: North America - 32%, Europe – 25%, APAC – 20%, Latin America – 14%, Middle East & Africa – 9%

Research Coverage

This report studies respiratory diagnostics market based on products and services, test type, disease indication, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions and respective countries.

Reasons to Buy the Report

The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or a combination of the below-mentioned five strategies.

This report provides insights into the following pointers:

Analysis of key drivers (increasing incidences of respiratory disorders, growing aging population and changing lifestyle, growing awareness about respiratory health, advancements in diagnostic technologies), restraints (high cost of diagnostic tests, limited reimbursement coverage, and lack of skilled professionals for advanced diagnostics), opportunities (increasing healthcare infrastructure and rising disposable incomes in emerging economies, rising demand for Point-of-care (POC) testing, and growing awareness of untreated sleep apnea), and challenges (complexity in diagnosing viral respiratory infections, and limited access to peripheral lung lesions in bronchoscopy) influencing the growth of respiratory diagnostics market.

Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in respiratory diagnostics market.

Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of respiratory diagnostics across regions.

Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in respiratory diagnostics market.

Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in respiratory diagnostics market.

Tables List

Table 1 Respiratory Diagnostics Market: Inclusions & Exclusions

Table 2 Exchange Rates Utilized For Conversion To Usd

Table 3 Respiratory Diagnostics Market: Study Assumptions

Table 4 Respiratory Diagnostics Market: Risk Assessment Analysis

Table 5 Awareness Initiatives On Effects Of Untreated Sleep Apnea

Table 6 Respiratory Diagnostics Market: Porter’s Five Forces Analysis

Table 7 North America: Regulatory Bodies, Government Agencies,

And Other Organizations

Table 8 Europe: Regulatory Bodies, Government Agencies, And Other Organizations

Table 9 Asia Pacific: Regulatory Bodies, Government Agencies,

And Other Organizations

Table 10 Latin America: Regulatory Bodies, Government Agencies,

And Other Organizations

Table 11 Middle East & Africa: Regulatory Bodies, Government Agencies,

And Other Organizations

Table 12 Us: Classification Of Medical Equipment

Table 13 Us: Time, Cost, And Complexity Of Registration Process

Table 14 Canada: Level Of Risk, Time, Cost, And Complexity Of Registration Process

Table 15 Europe: Level Of Risk, Time, Cost, And Complexity Of Registration Process

Table 16 China: Time, Cost, And Complexity Of Registration Process

Table 17 Japan: Time, Cost, And Complexity Of Registration Process

Table 18 Respiratory Diagnostics Market: Innovations And Patent

Registrations, 2022−2024

Table 19 Import Data For Hs Code 901819, By Country, 2019–2023 (Usd Thousand)

Table 20 Export Data For Hs Code 901819, By Country, 2019–2023 (Usd Thousand)

Table 21 Average Selling Price Trend Of Respiratory Diagnostic Products,

By Region, 2021–2023 (Usd)

Table 22 Influence Of Stakeholders On Buying Process For Respiratory

Diagnostic Devices

Table 23 Key Buying Criteria For Respiratory Diagnostic Devices

Table 24 Respiratory Diagnostics Market: Key Conferences & Events, 2024−2025

Table 25 Respiratory Diagnostics Market: Role In Ecosystem

Table 26 Case Study 1: Acupebble Sa100 – Transforming Sleep Apnea Diagnosis

Table 27 Case Study 2: Remote Monitoring Solution For Covid-19 Patients In Indonesia

Table 28 Case Study 3: Effective Management Of A 71-year-old Copd Patient

With Acute Exacerbations

Table 29 Respiratory Diagnostics Market: Reimbursement Scenario

Table 30 Respiratory Diagnostics Market, By Product & Service,

2022–2030 (Usd Million)

Table 31 Respiratory Diagnostics Market For Instruments & Devices,

By Country, 2022–2030 (Usd Million)

Table 32 Respiratory Diagnostics Market For Assays & Reagents,

By Country, 2022–2030 (Usd Million)

Table 33 Respiratory Diagnostics Market For Services & Software,

By Country, 2022–2030 (Usd Million)

Table 34 Respiratory Diagnostics Market, By Test Type, 2022–2030 (Usd Million)

Table 35 Respiratory Diagnostics Market For Mechanical Tests,

By Country, 2022–2030 (Usd Million)

Table 36 Respiratory Diagnostics Market For Mechanical Tests,

By Type, 2022–2030 (Usd Million)

Table 37 Respiratory Diagnostics Market For Pulmonary Function Tests,

By Country, 2022–2030 (Usd Million)

Table 38 Respiratory Diagnostics Market For Pulmonary Function Tests,

By Type, 2022–2030 (Usd Million)

Table 39 Spirometry Tests Market, By Country, 2022–2030 (Usd Million)

Table 40 Spirometry Tests Market, By Region, 2022–2030 (Thousand Units)

Table 41 Peak Flow Tests Market, By Country, 2022–2030 (Usd Million)

Table 42 Peak Flow Tests Market, By Region, 2022–2030 (Thousand Units)

Table 43 Other Pulmonary Tests Market, By Country, 2022–2030 (Usd Million)

Table 44 Other Pulmonary Tests Market, By Region, 2022–2030 (Thousand Units)

Table 45 Obstructive Sleep Apnea Diagnostic Tests Market,

By Country, 2022–2030 (Usd Million)

Table 46 Other Mechanical Tests Market, By Country, 2022–2030 (Usd Million)

Table 47 Respiratory Diagnostics Market For Imaging Tests,

By Country, 2022–2030 (Usd Million)

Table 48 Respiratory Diagnostics Market For Imaging Tests,

By Type, 2022–2030 (Usd Million)

Table 49 X-ray Market, By Country, 2022–2030 (Usd Million)

Table 50 Computed Tomography Market, By Country, 2022–2030 (Usd Million)

Table 51 Magnetic Resonance Imaging Market, By Country, 2022–2030 (Usd Million)

Table 52 Positron Emission Tomography Market, By Country, 2022–2030 (Usd Million)

Table 53 Other Imaging Tests Market, By Country, 2022–2030 (Usd Million)

Table 54 Respiratory Diagnostics Market For Traditional Diagnostic Tests,

By Country, 2022–2030 (Usd Million)

Table 55 Respiratory Diagnostics Market For Traditional Diagnostic Tests,

By Type, 2022–2030 (Usd Million)

Table 56 Immunodiagnostics Market, By Country, 2022–2030 (Usd Million)

Table 57 Biochemical Tests Market, By Country, 2022–2030 (Usd Million)

Table 58 Microscopy Market, By Country, 2022–2030 (Usd Million)

Table 59 Respiratory Diagnostics Market For Molecular Diagnostic Tests,

By Country, 2022–2030 (Usd Million)

Table 60 Respiratory Diagnostics Market For Molecular Diagnostic Tests,

By Type, 2022–2030 (Usd Million)

Table 61 Pcr Market, By Country, 2022–2030 (Usd Million)

Table 62 Nucleic Acid Amplification Test Market, By Country, 2022–2030 (Usd Million)

Table 63 In Situ Hybridization Market, By Country, 2022–2030 (Usd Million)

Table 64 Dna Sequencing & Next-generation Sequencing Market,

By Country, 2022–2030 (Usd Million)

Table 65 Microarrays Market, By Country, 2022–2030 (Usd Million)

Table 66 Other Molecular Diagnostic Tests Market,

By Country, 2022–2030 (Usd Million)

Table 67 Respiratory Diagnostics Market, By Disease Type, 2022–2030 (Usd Million)

Table 68 Respiratory Diagnostics Market For Tuberculosis,

By Country, 2022–2030 (Usd Million)

Table 69 Respiratory Diagnostics Market For Asthma,

By Country, 2022–2030 (Usd Million)

Table 70 Respiratory Diagnostics Market For Lung Cancer,

By Country, 2022–2030 (Usd Million)

Table 71 Respiratory Diagnostics Market For Lung Cancer,

By Type, 2022–2030 (Usd Million)

Table 72 Non-small-cell Lung Cancer Market, By Country, 2022–2030 (Usd Million)

Table 73 Small-cell Lung Cancer Market, By Country, 2022–2030 (Usd Million)

Table 74 Other Lung Cancers Market, By Country, 2022–2030 (Usd Million)

Table 75 Respiratory Diagnostics Market For Chronic Obstructive Pulmonary Disease, By Country, 2022–2030 (Usd Million)

Table 76 Respiratory Diagnostics Market For Pneumonia,

By Country, 2022–2030 (Usd Million)

Table 77 Respiratory Diagnostics Market For Other Diseases,

By Country, 2022–2030 (Usd Million)

Table 78 Respiratory Diagnostics Market, By Diagnosis Type, 2022–2030 (Usd Million)

Table 79 Syndromic Diagnosis Market, By Country, 2022–2030 (Usd Million)

Table 80 Etiological Diagnosis Market, By Country, 2022–2030 (Usd Million)

Table 81 Prognosis Diagnosis Market, By Country, 2022–2030 (Usd Million)

Table 82 Respiratory Diagnostics Market, By End User, 2022–2030 (Usd Million)

Table 83 Respiratory Diagnostics Market For Hospitals & Clinics,

By Country, 2022–2030 (Usd Million)

Table 84 Respiratory Diagnostics Market For Diagnostic Laboratories,

By Country, 2022–2030 (Usd Million)

Table 85 Respiratory Diagnostics Market For Long-term Care & Specialty Centers,

By Country, 2022–2030 (Usd Million)

Table 86 Respiratory Diagnostics Market For Academic & Research Institutes,

By Country, 2022–2030 (Usd Million)

Table 87 Respiratory Diagnostics Market, By Region, 2022–2030 (Usd Million)

Table 88 North America: Respiratory Diagnostics Market,

By Country, 2022–2030 (Usd Million)

Table 89 North America: Respiratory Diagnostics Market,

By Product & Service, 2022–2030 (Usd Million)

Table 90 North America: Respiratory Diagnostics Market,

By Test Type, 2022–2030 (Usd Million)

Table 91 North America: Mechanical Tests Market, By Type, 2022–2030 (Usd Million)

Table 92 North America: Pulmonary Function Tests Market,

By Type, 2022–2030 (Usd Million)

Table 93 North America: Imaging Tests Market, By Type, 2022–2030 (Usd Million)

Table 94 North America: Traditional Diagnostic Tests Market,

By Type, 2022–2030 (Usd Million)

Table 95 North America: Molecular Diagnostic Tests Market,

By Type, 2022–2030 (Usd Million)

Table 96 North America: Respiratory Diagnostics Market,

By Disease Type, 2022–2030 (Usd Million)

Table 97 North America: Lung Cancer Market, By Type, 2022–2030 (Usd Million)

Table 98 North America: Respiratory Diagnostics Market,

By Diagnosis Type, 2022–2030 (Usd Million)

Table 99 North America: Respiratory Diagnostics Market,

By End User, 2022–2030 (Usd Million)

Table 100 Us: Key Macroindicators

Table 101 Us: Respiratory Diagnostics Market, By Product & Service,

2022–2030 (Usd Million)

Table 102 Us: Respiratory Diagnostics Market, By Test Type, 2022–2030 (Usd Million)

Table 103 Us: Mechanical Tests Market, By Type, 2022–2030 (Usd Million)

Table 104 Us: Pulmonary Function Tests Market, By Type, 2022–2030 (Usd Million)

Table 105 Us: Imaging Tests Market, By Type, 2022–2030 (Usd Million)

Table 106 Us: Traditional Diagnostic Tests Market, By Type, 2022–2030 (Usd Million)

Table 107 Us: Molecular Diagnostic Tests Market, By Type, 2022–2030 (Usd Million)

Table 108 Us: Respiratory Diagnostics Market, By Disease Type, 2022–2030 (Usd Million)

Table 109 Us: Lung Cancer Market, By Type, 2022–2030 (Usd Million)

Table 110 Us: Respiratory Diagnostics Market, By Diagnosis Type,

2022–2030 (Usd Million)

Table 111 Us: Respiratory Diagnostics Market, By End User, 2022–2030 (Usd Million)

Table 112 Canada: Key Macroindicators

Table 113 Canada: Respiratory Diagnostics Market,

By Product & Service, 2022–2030 (Usd Million)

Table 114 Canada: Respiratory Diagnostics Market,

By Test Type, 2022–2030 (Usd Million)

Table 115 Canada: Mechanical Tests Market, By Type, 2022–2030 (Usd Million)

Table 116 Canada: Pulmonary Function Tests Market, By Type, 2022–2030 (Usd Million)

Table 117 Canada: Imaging Tests Market, By Type, 2022–2030 (Usd Million)

Table 118 Canada: Traditional Diagnostic Tests Market,

By Type, 2022–2030 (Usd Million)

Table 119 Canada: Molecular Diagnostic Tests Market, By Type, 2022–2030 (Usd Million)

Table 120 Canada: Respiratory Diagnostics Market,

By Disease Type, 2022–2030 (Usd Million)

Table 121 Canada: Lung Cancer Market, By Type, 2022–2030 (Usd Million)

Table 122 Canada: Respiratory Diagnostics Market,

By Diagnosis Type, 2022–2030 (Usd Million)

Table 123 Canada: Respiratory Diagnostics Market,

By End User, 2022–2030 (Usd Million)

Table 124 Europe: Respiratory Diagnostics Market,

By Country, 2022–2030 (Usd Million)

Table 125 Europe: Respiratory Diagnostics Market,

By Product & Service, 2022–2030 (Usd Million)

Table 126 Europe: Respiratory Diagnostics Market,

By Test Type, 2022–2030 (Usd Million)

Table 127 Europe: Mechanical Tests Market, By Type, 2022–2030 (Usd Million)

Table 128 Europe: Pulmonary Function Tests Market, By Type, 2022–2030 (Usd Million)

Table 129 Europe: Imaging Tests Market, By Type, 2022–2030 (Usd Million)

Table 130 Europe: Traditional Diagnostic Tests Market,

By Type, 2022–2030 (Usd Million)

Table 131 Europe: Molecular Diagnostic Tests Market, By Type, 2022–2030 (Usd Million)

Table 132 Europe: Respiratory Diagnostics Market, By Disease Type,

2022–2030 (Usd Million)

Table 133 Europe: Lung Cancer Market, By Type, 2022–2030 (Usd Million)

Table 134 Europe: Respiratory Diagnostics Market, By Diagnosis Type,

2022–2030 (Usd Million)

Table 135 Europe: Respiratory Diagnostics Market, By End User,

2022–2030 (Usd Million)

Table 136 Germany: Key Macroindicators

Table 137 Germany: Respiratory Diagnostics Market,

By Product & Service, 2022–2030 (Usd Million)

Table 138 Germany: Respiratory Diagnostics Market,

By Test Type, 2022–2030 (Usd Million)

Table 139 Germany: Mechanical Tests Market, By Type, 2022–2030 (Usd Million)

Table 140 Germany: Pulmonary Function Tests Market, By Type, 2022–2030 (Usd Million)

Table 141 Germany: Imaging Tests Market, By Type, 2022–2030 (Usd Million)

Table 142 Germany: Traditional Diagnostic Tests Market,

By Type, 2022–2030 (Usd Million)

Table 143 Germany: Molecular Diagnostic Tests Market,

By Type, 2022–2030 (Usd Million)

Table 144 Germany: Respiratory Diagnostics Market,

By Disease Type, 2022–2030 (Usd Million)

Table 145 Germany: Lung Cancer Market, By Type, 2022–2030 (Usd Million)

Table 146 Germany: Respiratory Diagnostics Market,

By Diagnosis Type, 2022–2030 (Usd Million)

Table 147 Germany: Respiratory Diagnostics Market,

By End User, 2022–2030 (Usd Million)

Table 148 Uk: Key Macroindicators

Table 149 Uk: Respiratory Diagnostics Market,

By Product & Service, 2022–2030 (Usd Million)

Table 150 Uk: Respiratory Diagnostics Market, By Test Type, 2022–2030 (Usd Million)

Table 151 Uk: Mechanical Tests Market, By Type, 2022–2030 (Usd Million)

Table 152 Uk: Pulmonary Function Tests Market, By Type, 2022–2030 (Usd Million)

Table 153 Uk: Imaging Tests Market, By Type, 2022–2030 (Usd Million)

Table 154 Uk: Traditional Diagnostic Tests Market, By Type, 2022–2030 (Usd Million)

Table 155 Uk: Molecular Diagnostic Tests Market, By Type, 2022–2030 (Usd Million)

Table 156 Uk: Respiratory Diagnostics Market, By Disease Type, 2022–2030 (Usd Million)

Table 157 Uk: Lung Cancer Market, By Type, 2022–2030 (Usd Million)

Table 158 Uk: Respiratory Diagnostics Market, By Diagnosis Type,

2022–2030 (Usd Million)

Table 159 Uk: Respiratory Diagnostics Market, By End User, 2022–2030 (Usd Million)

Table 160 France: Key Macroindicators

Table 161 France: Respiratory Diagnostics Market,

By Product & Service, 2022–2030 (Usd Million)

Table 162 France: Respiratory Diagnostics Market,

By Test Type, 2022–2030 (Usd Million)

Table 163 France: Mechanical Tests Market, By Type, 2022–2030 (Usd Million)

Table 164 France: Pulmonary Function Tests Market, By Type, 2022–2030 (Usd Million)

Table 165 France: Imaging Tests Market, By Type, 2022–2030 (Usd Million)

Table 166 France: Traditional Diagnostic Tests Market,

By Type, 2022–2030 (Usd Million)

Table 167 France: Molecular Diagnostic Tests Market, By Type, 2022–2030 (Usd Million)

Table 168 France: Respiratory Diagnostics Market,

By Disease Type, 2022–2030 (Usd Million)

Table 169 France: Lung Cancer Market, By Type, 2022–2030 (Usd Million)

Table 170 France: Respiratory Diagnostics Market,

By Diagnosis Type, 2022–2030 (Usd Million)

Table 171 France: Respiratory Diagnostics Market,

By End User, 2022–2030 (Usd Million)

Table 172 Italy: Key Macroindicators

Table 173 Italy: Respiratory Diagnostics Market,

By Product & Service, 2022–2030 (Usd Million)

Table 174 Italy: Respiratory Diagnostics Market, By Test Type, 2022–2030 (Usd Million)

Table 175 Italy: Mechanical Tests Market, By Type, 2022–2030 (Usd Million)

Table 176 Italy: Pulmonary Function Tests Market, By Type, 2022–2030 (Usd Million)

Table 177 Italy: Imaging Tests Market, By Type, 2022–2030 (Usd Million)

Table 178 Italy: Traditional Diagnostic Tests Market, By Type, 2022–2030 (Usd Million)

Table 179 Italy: Molecular Diagnostic Tests Market, By Type, 2022–2030 (Usd Million)

Table 180 Italy: Respiratory Diagnostics Market,

By Disease Type, 2022–2030 (Usd Million)

Table 181 Italy: Lung Cancer Market, By Type, 2022–2030 (Usd Million)

Table 182 Italy: Respiratory Diagnostics Market,

By Diagnosis Type, 2022–2030 (Usd Million)

Table 183 Italy: Respiratory Diagnostics Market, By End User, 2022–2030 (Usd Million)

Table 184 Spain: Key Macroindicators

Table 185 Spain: Respiratory Diagnostics Market, By Product & Service,

2022–2030 (Usd Million)

Table 186 Spain: Respiratory Diagnostics Market, By Test Type, 2022–2030 (Usd Million)

Table 187 Spain: Mechanical Tests Market, By Type, 2022–2030 (Usd Million)

Table 188 Spain: Pulmonary Function Tests Market, By Type, 2022–2030 (Usd Million)

Table 189 Spain: Imaging Tests Market, By Type, 2022–2030 (Usd Million)

Table 190 Spain: Traditional Diagnostic Tests Market, By Type, 2022–2030 (Usd Million)

Table 191 Spain: Molecular Diagnostic Tests Market, By Type, 2022–2030 (Usd Million)

Table 192 Spain: Respiratory Diagnostics Market, By Disease Type,

2022–2030 (Usd Million)

Table 193 Spain: Lung Cancer Market, By Type, 2022–2030 (Usd Million)

Table 194 Spain: Respiratory Diagnostics Market, By Diagnosis Type,

2022–2030 (Usd Million)

Table 195 Spain: Respiratory Diagnostics Market, By End User, 2022–2030 (Usd Million)

Table 196 Rest Of Europe: Respiratory Diagnostics Market,

By Product & Service, 2022–2030 (Usd Million)

Table 197 Rest Of Europe: Respiratory Diagnostics Market,

By Test Type, 2022–2030 (Usd Million)

Table 198 Rest Of Europe: Mechanical Tests Market, By Type, 2022–2030 (Usd Million)

Table 199 Rest Of Europe: Pulmonary Function Tests Market,

By Type, 2022–2030 (Usd Million)

Table 200 Rest Of Europe: Imaging Tests Market, By Type, 2022–2030 (Usd Million)

Table 201 Rest Of Europe: Traditional Diagnostic Tests Market,

By Type, 2022–2030 (Usd Million)

Table 202 Rest Of Europe: Molecular Diagnostic Tests Market,

By Type, 2022–2030 (Usd Million)

Table 203 Rest Of Europe: Respiratory Diagnostics Market,

By Disease Type, 2022–2030 (Usd Million)

Table 204 Rest Of Europe: Lung Cancer Market, By Type, 2022–2030 (Usd Million)

Table 205 Rest Of Europe: Respiratory Diagnostics Market,

By Diagnosis Type, 2022–2030 (Usd Million)

Table 206 Rest Of Europe: Respiratory Diagnostics Market,

By End User, 2022–2030 (Usd Million)

Table 207 Asia Pacific: Respiratory Diagnostics Market,

By Country, 2022–2030 (Usd Million)

Table 208 Asia Pacific: Respiratory Diagnostics Market,

By Product & Service, 2022–2030 (Usd Million)

Table 209 Asia Pacific: Respiratory Diagnostics Market,

By Test Type, 2022–2030 (Usd Million)

Table 210 Asia Pacific: Mechanical Tests Market, By Type, 2022–2030 (Usd Million)

Table 211 Asia Pacific: Pulmonary Function Tests Market,

By Type, 2022–2030 (Usd Million)

Table 212 Asia Pacific: Imaging Tests Market, By Type, 2022–2030 (Usd Million)

Table 213 Asia Pacific: Traditional Diagnostic Tests Market,

By Type, 2022–2030 (Usd Million)

Table 214 Asia Pacific: Molecular Diagnostic Tests Market,

By Type, 2022–2030 (Usd Million)

Table 215 Asia Pacific: Respiratory Diagnostics Market,

By Disease Type, 2022–2030 (Usd Million)

Table 216 Asia Pacific: Lung Cancer Market, By Type, 2022–2030 (Usd Million)

Table 217 Asia Pacific: Respiratory Diagnostics Market,

By Diagnosis Type, 2022–2030 (Usd Million)

Table 218 Asia Pacific: Respiratory Diagnostics Market,

By End User, 2022–2030 (Usd Million)

Table 219 Japan: Key Macroindicators

Table 220 Japan: Respiratory Diagnostics Market,

By Product & Service, 2022–2030 (Usd Million)

Table 221 Japan: Respiratory Diagnostics Market, By Test Type, 2022–2030 (Usd Million)

Table 222 Japan: Mechanical Tests Market, By Type, 2022–2030 (Usd Million)

Table 223 Japan: Pulmonary Function Tests Market, By Type, 2022–2030 (Usd Million)

Table 224 Japan: Imaging Tests Market, By Type, 2022–2030 (Usd Million)

Table 225 Japan: Traditional Diagnostic Tests Market, By Type, 2022–2030 (Usd Million)

Table 226 Japan: Molecular Diagnostic Tests Market, By Type, 2022–2030 (Usd Million)

Table 227 Japan: Respiratory Diagnostics Market, By Disease Type,

2022–2030 (Usd Million)

Table 228 Japan: Lung Cancer Market, By Type, 2022–2030 (Usd Million)

Table 229 Japan: Respiratory Diagnostics Market, By Diagnosis Type,

2022–2030 (Usd Million)

Table 230 Japan: Respiratory Diagnostics Market, By End User, 2022–2030 (Usd Million)

Table 231 China: Key Macroindicators

Table 232 China: Respiratory Diagnostics Market, By Product & Service,

2022–2030 (Usd Million)

Table 233 China: Respiratory Diagnostics Market, By Test Type, 2022–2030 (Usd Million)

Table 234 China: Mechanical Tests Market, By Type, 2022–2030 (Usd Million)

Table 235 China: Pulmonary Function Tests Market, By Type, 2022–2030 (Usd Million)

Table 236 China: Imaging Tests Market, By Type, 2022–2030 (Usd Million)

Table 237 China: Traditional Diagnostic Tests Market, By Type, 2022–2030 (Usd Million)

Table 238 China: Molecular Diagnostic Tests Market, By Type, 2022–2030 (Usd Million)

Table 239 China: Respiratory Diagnostics Market, By Disease Type,

2022–2030 (Usd Million)

Table 240 China: Lung Cancer Market, By Type, 2022–2030 (Usd Million)

Table 241 China: Respiratory Diagnostics Market, By Diagnosis Type,

2022–2030 (Usd Million)

Table 242 China: Respiratory Diagnostics Market, By End User,

2022–2030 (Usd Million)

Table 243 India: Key Macroindicators

Table 244 India: Respiratory Diagnostics Market, By Product & Service,

2022–2030 (Usd Million)

Table 245 India: Respiratory Diagnostics Market, By Test Type, 2022–2030 (Usd Million)

Table 246 India: Mechanical Tests Market, By Type, 2022–2030 (Usd Million)

Table 247 India: Pulmonary Function Tests Market, By Type, 2022–2030 (Usd Million)

Table 248 India: Imaging Tests Market, By Type, 2022–2030 (Usd Million)

Table 249 India: Traditional Diagnostic Tests Market, By Type, 2022–2030 (Usd Million)

Table 250 India: Molecular Diagnostic Tests Market, By Type, 2022–2030 (Usd Million)

Table 251 India: Respiratory Diagnostics Market, By Disease Type,

2022–2030 (Usd Million)

Table 252 India: Lung Cancer Market, By Type, 2022–2030 (Usd Million)

Table 253 India: Respiratory Diagnostics Market, By Diagnosis Type,

2022–2030 (Usd Million)

Table 254 India: Respiratory Diagnostics Market, By End User,

2022–2030 (Usd Million)

Table 255 Australia: Key Macroindicators

Table 256 Australia: Respiratory Diagnostics Market,

By Product & Service, 2022–2030 (Usd Million)

Table 257 Australia: Respiratory Diagnostics Market,

By Test Type, 2022–2030 (Usd Million)

Table 258 Australia: Mechanical Tests Market, By Type, 2022–2030 (Usd Million)

Table 259 Australia: Pulmonary Function Tests Market,

By Type, 2022–2030 (Usd Million)

Table 260 Australia: Imaging Tests Market, By Type, 2022–2030 (Usd Million)

Table 261 Australia: Traditional Diagnostic Tests Market,

By Type, 2022–2030 (Usd Million)

Table 262 Australia: Molecular Diagnostic Tests Market,

By Type, 2022–2030 (Usd Million)

Table 263 Australia: Respiratory Diagnostics Market,

By Disease Type, 2022–2030 (Usd Million)

Table 264 Australia: Lung Cancer Market, By Type, 2022–2030 (Usd Million)

Table 265 Australia: Respiratory Diagnostics Market,

By Diagnosis Type, 2022–2030 (Usd Million)

Table 266 Australia: Respiratory Diagnostics Market,

By End User, 2022–2030 (Usd Million)

Table 267 South Korea: Key Macroindicators

Table 268 South Korea: Respiratory Diagnostics Market,

By Product & Service, 2022–2030 (Usd Million)

Table 269 South Korea: Respiratory Diagnostics Market,

By Test Type, 2022–2030 (Usd Million)

Table 270 South Korea: Mechanical Tests Market, By Type, 2022–2030 (Usd Million)

Table 271 South Korea: Pulmonary Function Tests Market,

By Type, 2022–2030 (Usd Million)

Table 272 South Korea: Imaging Tests Market, By Type, 2022–2030 (Usd Million)

Table 273 South Korea: Traditional Diagnostic Tests Market,

By Type, 2022–2030 (Usd Million)

Table 274 South Korea: Molecular Diagnostic Tests Market,

By Type, 2022–2030 (Usd Million)

Table 275 South Korea: Respiratory Diagnostics Market,

By Disease Type, 2022–2030 (Usd Million)

Table 276 South Korea: Lung Cancer Market, By Type, 2022–2030 (Usd Million)

Table 277 South Korea: Respiratory Diagnostics Market,

By Diagnosis Type, 2022–2030 (Usd Million)

Table 278 South Korea: Respiratory Diagnostics Market,

By End User, 2022–2030 (Usd Million)

Table 279 Rest Of Asia Pacific: Respiratory Diagnostics Market,

By Product & Service, 2022–2030 (Usd Million)

Table 280 Rest Of Asia Pacific: Respiratory Diagnostics Market,

By Test Type, 2022–2030 (Usd Million)

Table 281 Rest Of Asia Pacific: Mechanical Tests Market,

By Type, 2022–2030 (Usd Million)

Table 282 Rest Of Asia Pacific: Pulmonary Function Tests Market,

By Type, 2022–2030 (Usd Million)

Table 283 Rest Of Asia Pacific: Imaging Tests Market, By Type, 2022–2030 (Usd Million)

Table 284 Rest Of Asia Pacific: Traditional Diagnostic Tests Market,

By Type, 2022–2030 (Usd Million)

Table 285 Rest Of Asia Pacific: Molecular Diagnostic Tests Market,

By Type, 2022–2030 (Usd Million)

Table 286 Rest Of Asia Pacific: Respiratory Diagnostics Market,

By Disease Type, 2022–2030 (Usd Million)

Table 287 Rest Of Asia Pacific: Lung Cancer Market, By Type, 2022–2030 (Usd Million)

Table 288 Rest Of Asia Pacific: Respiratory Diagnostics Market,

By Diagnosis Type, 2022–2030 (Usd Million)

Table 289 Rest Of Asia Pacific: Respiratory Diagnostics Market,

By End User, 2022–2030 (Usd Million)

Table 290 Latin America: Respiratory Diagnostics Market,

By Country, 2022–2030 (Usd Million)

Table 291 Latin America: Respiratory Diagnostics Market,

By Product & Service, 2022–2030 (Usd Million)

Table 292 Latin America: Respiratory Diagnostics Market,

By Test Type, 2022–2030 (Usd Million)

Table 293 Latin America: Mechanical Tests Market, By Type, 2022–2030 (Usd Million)

Table 294 Latin America: Pulmonary Function Tests Market,

By Type, 2022–2030 (Usd Million)

Table 295 Latin America: Imaging Tests Market, By Type, 2022–2030 (Usd Million)

Table 296 Latin America: Traditional Diagnostic Tests Market,

By Type, 2022–2030 (Usd Million)

Table 297 Latin America: Molecular Diagnostic Tests Market,

By Type, 2022–2030 (Usd Million)

Table 298 Latin America: Respiratory Diagnostics Market,

By Disease Type, 2022–2030 (Usd Million)

Table 299 Latin America: Lung Cancer Market, By Type, 2022–2030 (Usd Million)

Table 300 Latin America: Respiratory Diagnostics Market,

By Diagnosis Type, 2022–2030 (Usd Million)

Table 301 Latin America: Respiratory Diagnostics Market,

By End User, 2022–2030 (Usd Million)

Table 302 Brazil: Key Macroindicators

Table 303 Brazil: Respiratory Diagnostics Market,

By Product & Service, 2022–2030 (Usd Million)

Table 304 Brazil: Respiratory Diagnostics Market,

By Test Type, 2022–2030 (Usd Million)

Table 305 Brazil: Mechanical Tests Market, By Type, 2022–2030 (Usd Million)

Table 306 Brazil: Pulmonary Function Tests Market, By Type, 2022–2030 (Usd Million)

Table 307 Brazil: Imaging Tests Market, By Type, 2022–2030 (Usd Million)

Table 308 Brazil: Traditional Diagnostic Tests Market, By Type, 2022–2030 (Usd Million)

Table 309 Brazil: Molecular Diagnostic Tests Market, By Type, 2022–2030 (Usd Million)

Table 310 Brazil: Respiratory Diagnostics Market, By Disease Type,

2022–2030 (Usd Million)

Table 311 Brazil: Lung Cancer Market, By Type, 2022–2030 (Usd Million)

Table 312 Brazil: Respiratory Diagnostics Market, By Diagnosis Type,

2022–2030 (Usd Million)

Table 313 Brazil: Respiratory Diagnostics Market, By End User,

2022–2030 (Usd Million)

Table 314 Mexico: Key Macroindicators

Table 315 Mexico: Respiratory Diagnostics Market, By Product & Service,

2022–2030 (Usd Million)

Table 316 Mexico: Respiratory Diagnostics Market, By Test Type,

2022–2030 (Usd Million)

Table 317 Mexico: Mechanical Tests Market, By Type, 2022–2030 (Usd Million)

Table 318 Mexico: Pulmonary Function Tests Market, By Type, 2022–2030 (Usd Million)

Table 319 Mexico: Imaging Tests Market, By Type, 2022–2030 (Usd Million)

Table 320 Mexico: Traditional Diagnostic Tests Market, By Type, 2022–2030 (Usd Million)

Table 321 Mexico: Molecular Diagnostic Tests Market, By Type, 2022–2030 (Usd Million)

Table 322 Mexico: Respiratory Diagnostics Market, By Disease Type,

2022–2030 (Usd Million)

Table 323 Mexico: Lung Cancer Market, By Type, 2022–2030 (Usd Million)

Table 324 Mexico: Respiratory Diagnostics Market, By Diagnosis Type,

2022–2030 (Usd Million)

Table 325 Mexico: Respiratory Diagnostics Market, By End User,

2022–2030 (Usd Million)

Table 326 Rest Of Latin America: Respiratory Diagnostics Market,

By Product & Service, 2022–2030 (Usd Million)

Table 327 Rest Of Latin America: Respiratory Diagnostics Market,

By Test Type, 2022–2030 (Usd Million)

Table 328 Rest Of Latin America: Mechanical Tests Market,

By Type, 2022–2030 (Usd Million)

Table 329 Rest Of Latin America: Pulmonary Function Tests Market,

By Type, 2022–2030 (Usd Million)

Table 330 Rest Of Latin America: Imaging Tests Market, By Type, 2022–2030 (Usd Million)

Table 331 Rest Of Latin America: Traditional Diagnostic Tests Market,

By Type, 2022–2030 (Usd Million)

Table 332 Rest Of Latin America: Molecular Diagnostic Tests Market,

By Type, 2022–2030 (Usd Million)

Table 333 Rest Of Latin America: Respiratory Diagnostics Market,

By Disease Type, 2022–2030 (Usd Million)

Table 334 Rest Of Latin America: Lung Cancer Market, By Type, 2022–2030 (Usd Million)

Table 335 Rest Of Latin America: Respiratory Diagnostics Market,

By Diagnosis Type, 2022–2030 (Usd Million)

Table 336 Rest Of Latin America: Respiratory Diagnostics Market,

By End User, 2022–2030 (Usd Million)

Table 337 Middle East & Africa: Respiratory Diagnostics Market,

By Region, 2022–2030 (Usd Million)

Table 338 Middle East & Africa: Respiratory Diagnostics Market,

By Product & Service, 2022–2030 (Usd Million)

Table 339 Middle East & Africa: Respiratory Diagnostics Market,

By Test Type, 2022–2030 (Usd Million)

Table 340 Middle East & Africa: Mechanical Tests Market,

By Type, 2022–2030 (Usd Million)

Table 341 Middle East & Africa: Pulmonar y Function Tests Market,

By Type, 2022–2030 (Usd Million)

Table 342 Middle East & Africa: Imaging Tests Market, By Type, 2022–2030 (Usd Million)

Table 343 Middle East & Africa: Traditional Diagnostic Tests Market,

By Type, 2022–2030 (Usd Million)

Table 344 Middle East & Africa: Molecular Diagnostic Tests Market,

By Type, 2022–2030 (Usd Million)

Table 345 Middle East & Africa: Respiratory Diagnostics Market,

By Disease Type, 2022–2030 (Usd Million)

Table 346 Middle East & Africa: Lung Cancer Market, By Type, 2022–2030 (Usd Million)

Table 347 Middle East & Africa: Respiratory Diagnostics Market,

By Diagnosis Type, 2022–2030 (Usd Million)

Table 348 Middle East & Africa: Respiratory Diagnostics Market,

By End User, 2022–2030 (Usd Million)

Table 349 Gcc Countries: Respiratory Diagnostics Market,

By Country, 2022–2030 (Usd Million)

Table 350 Gcc Countries: Respiratory Diagnostics Market,

By Product & Service, 2022–2030 (Usd Million)

Table 351 Gcc Countries: Respiratory Diagnostics Market,

By Test Type, 2022–2030 (Usd Million)

Table 352 Gcc Countries: Mechanical Tests Market, By Type, 2022–2030 (Usd Million)

Table 353 Gcc Countries: Pulmonary Function Tests Market,

By Type, 2022–2030 (Usd Million)

Table 354 Gcc Countries: Imaging Tests Market, By Type, 2022–2030 (Usd Million)

Table 355 Gcc Countries: Traditional Diagnostic Tests Market,

By Type, 2022–2030 (Usd Million)

Table 356 Gcc Countries: Molecular Diagnostic Tests Market,

By Type, 2022–2030 (Usd Million)

Table 357 Gcc Countries: Respiratory Diagnostics Market,

By Disease Type, 2022–2030 (Usd Million)

Table 358 Gcc Countries: Lung Cancer Market, By Type, 2022–2030 (Usd Million)

Table 359 Gcc Countries: Respiratory Diagnostics Market,

By Diagnosis Type, 2022–2030 (Usd Million)

Table 360 Gcc Countries: Respiratory Diagnostics Market,

By End User, 2022–2030 (Usd Million)

Table 361 Kingdom Of Saudi Arabia: Key Macroindicators

Table 362 Kingdom Of Saudi Arabia: Respiratory Diagnostics Market,

By Product & Service, 2022–2030 (Usd Million)

Table 363 Kingdom Of Saudi Arabia: Respiratory Diagnostics Market,

By Test Type, 2022–2030 (Usd Million)

Table 364 Kingdom Of Saudi Arabia: Mechanical Tests Market,

By Type, 2022–2030 (Usd Million)

Table 365 Kingdom Of Saudi Arabia: Pulmonary Function Tests Market,

By Type, 2022–2030 (Usd Million)

Table 366 Kingdom Of Saudi Arabia: Imaging Tests Market,

By Type, 2022–2030 (Usd Million)

Table 367 Kingdom Of Saudi Arabia: Traditional Diagnostic Tests Market,

By Type, 2022–2030 (Usd Million)

Table 368 Kingdom Of Saudi Arabia: Molecular Diagnostic Tests Market,

By Type, 2022–2030 (Usd Million)

Table 369 Kingdom Of Saudi Arabia: Respiratory Diagnostics Market,

By Disease Type, 2022–2030 (Usd Million)

Table 370 Kingdom Of Saudi Arabia: Lung Cancer Market,

By Type, 2022–2030 (Usd Million)

Table 371 Kingdom Of Saudi Arabia: Respiratory Diagnostics Market,

By Diagnosis Type, 2022–2030 (Usd Million)

Table 372 Kingdom Of Saudi Arabia: Respiratory Diagnostics Market,

By End User, 2022–2030 (Usd Million)

Table 373 United Arab Emirates: Key Macroindicators

Table 374 United Arab Emirates: Respiratory Diagnostics Market,

By Product & Service, 2022–2030 (Usd Million)

Table 375 United Arab Emirates: Respiratory Diagnostics Market,

By Test Type, 2022–2030 (Usd Million)

Table 376 United Arab Emirates: Mechanical Tests Market,

By Type, 2022–2030 (Usd Million)

Table 377 United Arab Emirates: Pulmonary Function Tests Market,

By Type, 2022–2030 (Usd Million)

Table 378 United Arab Emirates: Imaging Tests Market, By Type, 2022–2030 (Usd Million)

Table 379 United Arab Emirates: Traditional Diagnostic Tests Market,

By Type, 2022–2030 (Usd Million)

Table 380 United Arab Emirates: Molecular Diagnostic Tests Market,

By Type, 2022–2030 (Usd Million)

Table 381 United Arab Emirates: Respiratory Diagnostics Market,

By Disease Type, 2022–2030 (Usd Million)

Table 382 United Arab Emirates: Lung Cancer Market, By Type, 2022–2030 (Usd Million)

Table 383 United Arab Emirates: Respiratory Diagnostics Market,

By Diagnosis Type, 2022–2030 (Usd Million)

Table 384 United Arab Emirates: Respiratory Diagnostics Market,

By End User, 2022–2030 (Usd Million)

Table 385 Other Gcc Countries: Respiratory Diagnostics Market,

By Product & Service, 2022–2030 (Usd Million)

Table 386 Other Gcc Countries: Respiratory Diagnostics Market,

By Test Type, 2022–2030 (Usd Million)

Table 387 Other Gcc Countries: Mechanical Tests Market,

By Type, 2022–2030 (Usd Million)

Table 388 Other Gcc Countries: Pulmonary Function Tests Market,

By Type, 2022–2030 (Usd Million)

Table 389 Other Gcc Countries: Imaging Tests Market, By Type, 2022–2030 (Usd Million)

Table 390 Other Gcc Countries: Traditional Diagnostic Tests Market,

By Type, 2022–2030 (Usd Million)

Table 391 Other Gcc Countries: Molecular Diagnostic Tests Market,

By Type, 2022–2030 (Usd Million)

Table 392 Other Gcc Countries: Respiratory Diagnostics Market,

By Disease Type, 2022–2030 (Usd Million)

Table 393 Other Gcc Countries: Lung Cancer Market, By Type, 2022–2030 (Usd Million)

Table 394 Other Gcc Countries: Respiratory Diagnostics Market,

By Diagnosis Type, 2022–2030 (Usd Million)

Table 395 Other Gcc Countries: Respiratory Diagnostics Market,

By End User, 2022–2030 (Usd Million)

Table 396 Rest Of Middle East & Africa: Respiratory Diagnostics Market,

By Product & Service, 2022–2030 (Usd Million)

Table 397 Rest Of Middle East & Africa: Respiratory Diagnostics Market,

By Test Type, 2022–2030 (Usd Million)

Table 398 Rest Of Middle East & Africa: Mechanical Tests Market,

By Type, 2022–2030 (Usd Million)

Table 399 Rest Of Middle East & Africa: Pulmonary Function Tests Market,

By Type, 2022–2030 (Usd Million)

Table 400 Rest Of Middle East & Africa: Imaging Tests Market,

By Type, 2022–2030 (Usd Million)

Table 401 Rest Of Middle East & Africa: Traditional Diagnostic Tests Market,

By Type, 2022–2030 (Usd Million)

Table 402 Rest Of Middle East & Africa: Molecular Diagnostic Tests Market,

By Type, 2022–2030 (Usd Million)

Table 403 Rest Of Middle East & Africa: Respiratory Diagnostics Market,

By Disease Type, 2022–2030 (Usd Million)

Table 404 Rest Of Middle East & Africa: Lung Cancer Market,

By Type, 2022–2030 (Usd Million)

Table 405 Rest Of Middle East & Africa: Respiratory Diagnostics Market,

By Diagnosis Type, 2022–2030 (Usd Million)

Table 406 Rest Of Middle East & Africa: Respiratory Diagnostics Market,

By End User, 2022–2030 (Usd Million)

Table 407 Respiratory Diagnostic Market: Overview Of Strategies Adopted

By Key Players, January 2021–december 2024

Table 408 Respiratory Diagnostics Market: Degree Of Competition, 2023

Table 409 Respiratory Diagnostics Market: Regional Footprint

Table 410 Respiratory Diagnostics Market: Product & Service Footprint

Table 411 Respiratory Diagnostics Market: Test Type Footprint

Table 412 Respiratory Diagnostics Market: Disease Type Footprint

Table 413 Respiratory Diagnostics Market: End-user Footprint

Table 414 Respiratory Diagnostics Market: Detailed List Of Key Startup/Sme Players

Table 415 Respiratory Diagnostics Market: Competitive Benchmarking

Of Key Emerging Players/Startups

Table 416 Respiratory Diagnostics Market: Product & Service Launches

And Approvals, January 2021–december 2024

Table 417 Respiratory Diagnostics Market: Deals, January 2021–december 2024

Table 418 Respiratory Diagnostics Market: Expansions, January 2021–december 2024

Table 419 Respiratory Diagnostics Market: Other Developments,

January 2021–december 2024

Table 420 Koninklijke Philips N.V.: Company Overview

Table 421 Koninklijke Philips N.V.: Products & Services Offered

Table 422 Koninklijke Philips N.V.: Product Launches, January 2021–december 2024

Table 423 Koninklijke Philips N.V.: Deals, January 2021–december 2024

Table 424 Koninklijke Philips N.V.: Expansions, January 2021–december 2024

Table 425 Becton, Dickinson And Company: Company Overview

Table 426 Becton, Dickinson And Company: Products & Services Offered

Table 427 Becton, Dickinson And Company: Product Launches & Approvals,

January 2021–december 2024

Table 428 Becton, Dickinson And Company: Deals, January 2021–december 2024

Table 429 Abbott Laboratories: Company Overview

Table 430 Abbott Laboratories: Products & Services Offered

Table 431 Abbott Laboratories: Product Approvals, January 2021–december 2024

Table 432 Thermo Fisher Scientific Inc.: Company Overview

Table 433 Thermo Fisher Scientific Inc.: Products & Services Offered

Table 434 Thermo Fisher Scientific Inc.: Product & Service Launches,

January 2021–december 2024

Table 435 Thermo Fisher Scientific Inc.: Deals, January 2021–december 2024

Table 436 Ge Healthcare Technologies, Inc.: Company Overview

Table 437 Ge Healthcare Technologies, Inc.: Products & Services Offered

Table 438 Ge Healthcare Technologies, Inc.: Product & Service Launches & Approvals, January 2021–december 2024

Table 439 Ge Healthcare Technologies, Inc.: Deals, January 2021–december 2024

Table 440 Ge Healthcare Technologies, Inc.: Other Developments,

January 2021–march 2024

Table 441 Bio-rad Laboratories, Inc.: Company Overview

Table 442 Bio-rad Laboratories, Inc.: Products & Services Offered

Table 443 Bio-rad Laboratories, Inc.: Product Launches & Approvals,

January 2021–december 2024

Table 444 Bio-rad Laboratories, Inc.: Deals, January 2021–december 2024

Table 445 Biomérieux: Company Overview

Table 446 Biomérieux: Products & Services Offered

Table 447 Biomérieux: Product Launches & Approvals, January 2021–december 2024

Table 448 Biomérieux: Deals, January 2021–december 2024

Table 449 Revvity, Inc.: Company Overview

Table 450 Revvity, Inc.: Products & Services Offered

Table 451 Revvity, Inc.: Product Launches & Approvals, January 2021–december 2024

Table 452 Revvity, Inc.: Deals, January 2021–december 2024

Table 453 Seegene Inc.: Company Overview

Table 454 Seegene Inc.: Products & Services Offered

Table 455 Seegene Inc.: Product Launches & Approvals, January 2021–december 2024

Table 456 Seegene Inc.: Deals, January 2021–december 2024

Table 457 Seegene Inc.: Expansions, January 2021–december 2024

Table 458 Seegene Inc.: Other Developments, January 2021–march 2024

Table 459 Nihon Kohden Corporation: Company Overview

Table 460 Nihon Kohden Corporation: Products & Services Offered

Table 461 Vitalograph: Company Overview

Table 462 Vitalograph: Products & Services Offered

Table 463 Vitalograph: Product & Service Launches & Approvals,

January 2021–december 2024

Table 464 Vitalograph: Deals, January 2021–december 2024

Table 465 Sdi Diagnostics: Company Overview

Table 466 Sdi Diagnostics: Products & Services Offered

Table 467 Resmed Inc.: Company Overview

Table 468 Resmed Inc.: Products & Services Offered

Table 469 Resmed Inc.: Deals, January 2021–december 2024

Table 470 Resmed Inc.: Expansions, January 2021–december 2024

Table 471 Resmed Inc.: Other Developments, January 2021–december 2024

Table 472 Siemens Healthineers Ag: Company Overview

Table 473 Siemens Healthineers Ag: Products & Services Offered

Table 474 Siemens Healthineers Ag: Product Launches, January 2021–december 2024

Table 475 Siemens Healthineers Ag: Deals, January 2021–december 2024

Table 476 Siemens Healthineers Ag: Expansions, January 2021–december 2024

Table 477 Cosmed Srl: Company Overview

Table 478 Cosmed Srl: Products & Services Offered

Table 479 Cosmed Srl: Product Launches, January 2021–december 2024

Table 480 Cosmed Srl: Deals, January 2021–december 2024

Table 481 Hologic, Inc.: Company Overview

Table 482 Hologic, Inc.: Products & Services Offered

Table 483 Hologic, Inc.: Product Launches, January 2021–december 2024

Table 484 Hologic, Inc.: Deals, January 2021–december 2024

Table 485 Qiagen N.V.: Company Overview

Table 486 Qiagen N.V.: Products & Services Offered

Table 487 Qiagen N.V.: Product Launches, January 2021–december 2024

Table 488 Qiagen N.V.: Deals, January 2021–december 2024

Table 489 Qiagen N.V.: Other Developments, January 2021–march 2024

Figures List

Figure 1 Respiratory Diagnostics Market: Market & Regional Spread

Figure 2 Respiratory Diagnostics Market: Years Considered

Figure 3 Research Design

Figure 4 Respiratory Diagnostics Market: Key Primary Sources

Figure 5 Respiratory Diagnostics Market: Key Data From Primary Sources

Figure 6 Respiratory Diagnostics Market: Key Industry Insights

Figure 7 Breakdown Of Primary Interviews: Supply-side And Demand-side Participants

Figure 8 Breakdown Of Primary Interviews (Supply Side): By Company Type, Designation, And Region

Figure 9 Breakdown Of Primary Interviews (Demand Side):

By End User, Designation, And Region

Figure 10 Supply-side Market Size Estimation: Revenue Share Analysis

Figure 11 Revenue Share Analysis Illustration: Koninklijke Philips N.V. (2023)

Figure 12 Supply-side Analysis: Respiratory Diagnostics Market (2023)

Figure 13 Respiratory Diagnostics Market: Top-down Approach

Figure 14 Cagr Projections From Analysis Of Drivers, Restraints,

Opportunities, And Challenges

Figure 15 Cagr Projections: Supply-side Analysis

Figure 16 Respiratory Diagnostics Market: Data Triangulation Methodology

Figure 17 Respiratory Diagnostics Market, By Product & Service,

2024 Vs. 2030 (Usd Million)

Figure 18 Respiratory Diagnostics Market, By Test Type, 2024 Vs. 2030 (Usd Million)

Figure 19 Respiratory Diagnostics Market, By Disease Type, 2024 Vs. 2030 (Usd Million)

Figure 20 Respiratory Diagnostics Market, By Diagnosis Type,

2024 Vs. 2030 (Usd Million)

Figure 21 Respiratory Diagnostics Market, By End User, 2024 Vs. 2030 (Usd Million)

Figure 22 Geographic Snapshot Of Respiratory Diagnostics Market

Figure 23 Rising Prevalence Of Respiratory Diseases To Propel Market

Figure 24 Instruments & Devices Segment Accounted For Largest Market Share

In China (2023)

Figure 25 Asia Pacific To Register Highest Growth Rate During Forecast Period

Figure 26 India To Grow At Highest Growth Rate During Forecast Period

Figure 27 Respiratory Diagnostics Market: Drivers, Restraints, Opportunities,

And Challenges

Figure 28 Chronic Obstructive Pulmonary Disease (Copd) Daly For Individuals

In Australia, By Age (2023)

Figure 29 Global Geriatric Population, By Region

Figure 30 Respiratory Diagnostics Market: Porter’s Five Forces Analysis

Figure 31 Number Of Patents Published, January 2014–december 2024

Figure 32 Top Patent Applicants And Owners (Companies/Institutes) For Respiratory Diagnostics Devices (January 2014– December 2024)

Figure 33 Top Patent Applicants, By Jurisdiction, January 2014−december 2024

Figure 34 Average Selling Price Of Spirometers, By Key Player (2024)

Figure 35 Average Selling Price Of Peak Flowmeters, By Key Player (2024)

Figure 36 Respiratory Diagnostics Market: Value Chain Analysis

Figure 37 Influence Of Stakeholders On Buying Process For Respiratory

Diagnostic Devices

Figure 38 Key Buying Criteria For Respiratory Diagnostic Devices

Figure 39 Respiratory Diagnostics Market: Adjacent Markets

Figure 40 Respiratory Diagnostics Market: Ecosystem Analysis

Figure 41 Respiratory Diagnostics Market: Supply Chain Analysis

Figure 42 Respiratory Diagnostics Market: Trends/Disruptions Impacting

Customers’ Businesses

Figure 43 Respiratory Diagnostics Market: Number Of Deals, 2020–2024

Figure 44 Respiratory Diagnostics Market: Impact Of Ai/Gen Ai

Figure 45 Respiratory Diagnostics Market Snapshot

Figure 46 North America: Respiratory Diagnostics Market Snapshot

Figure 47 Asia Pacific: Respiratory Diagnostics Market Snapshot

Figure 48 Respiratory Diagnostics Market: Revenue Analysis

Of Key Players, 2019−2023

Figure 49 Market Share Analysis Of Key Players In Respiratory

Diagnostics Market (2023)

Figure 50 Ranking Of Key Players In Respiratory Diagnostics Market, 2023

Figure 51 Respiratory Diagnostics Market: Company Evaluation Matrix

(Key Players), 2023

Figure 52 Respiratory Diagnostics Market: Company Footprint

Figure 53 Respiratory Diagnostics Market: Company Evaluation Matrix (Startups/Smes), 2023

Figure 54 Respiratory Diagnostics Market: Brand/Product Comparative Analysis

Figure 55 R&D Expenditure Of Key Players In Respiratory Diagnostics

Market, 2022−2024

Figure 56 Ev/Ebitda Of Key Vendors

Figure 57 Year-to-date (Ytd) Price Total Return And 5-year Stock Beta Of Key Vendors

Figure 58 Koninklijke Philips N.V.: Company Snapshot (2023)

Figure 59 Becton, Dickinson And Company: Company Snapshot (2024)

Figure 60 Abbott Laboratories: Company Snapshot (2023)

Figure 61 Thermo Fisher Scientific Inc.: Company Snapshot (2023)

Figure 62 Ge Healthcare Technologies, Inc.: Company Snapshot (2023)

Figure 63 Bio-rad Laboratories, Inc.: Company Snapshot (2023)

Figure 64 Biomérieux: Company Snapshot (2023)

Figure 65 Revvity, Inc.: Company Snapshot (2023)

Figure 66 Seegene Inc.: Company Snapshot (2023)

Figure 67 Nihon Kohden Corporation: Company Snapshot (2023)

Figure 68 Resmed Inc.: Company Snapshot (2024)

Figure 69 Siemens Healthineers Ag: Company Snapshot (2024)

Figure 70 Hologic, Inc.: Company Snapshot (2024)

Figure 71 Qiagen N.V.: Company Snapshot (2023)